The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Rapamycin increases lifespan and inhibits spontaneous tumorigenesis in inbred female mice
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Rapamycin-induced longevity extension (which in flies partially depends on autophagy induction) can be obtained by constant-long term exposure, as well as by intermittent regimens 156”
From Hallmarks of aging: An expanding universe (2023) · cites this paper as [156]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rapamycin fed late in life extends lifespan in genetically heterogeneous mice
Harrison, D. E., Strong, R., Sharp, Z. D., Nelson, J. F., Astle, C. M., Flurkey, K., Nadon, N. L., Wilkinson, J. E., Frenkel, K., Carter, C. S., et al. (2009) · Nature · doi:10.1038/nature08221 · Cited by 3,766
Extending Healthy Life Span—From Yeast to Humans
Fontana, L., Partridge, L., & Longo, V. D. (2010) · Science · doi:10.1126/science.1172539 · Cited by 3,023
Ribosomal Protein S6 Kinase 1 Signaling Regulates Mammalian Life Span
Selman, C., Tullet, J. M. A., Wieser, D., Irvine, E., Lingard, S. J., Choudhury, A. I., Claret, M., Al-Qassab, H., Carmignac, D., Ramadani, F., et al. (2009) · Science · doi:10.1126/science.1177221 · Cited by 1,120 · cited 1×
“TOR accelerates aging in diverse organisms, from worms to mammals.(17-25) In mammals, mTOR (mammalian TOR) controls cellular mass growth, functions and metabolism in response to nutrients, hormones, cytokines and growth factors.”
BackgroundInfluence of TOR kinase on lifespan in C. elegans
Vellai, T., Takacs-Vellai, K., Zhang, Y., Kovacs, A. L., Orosz, L., & Müller, F. (2003) · Nature · doi:10.1038/426620a · Cited by 1,057
Dazert, E., & Hall, M. N. (2011) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2011.09.003 · Cited by 460
Anisimov, V. N., Berstein, L. M., Egormin, P. A., Piskunova, T. S., Popovich, I. G., Zabezhinski, M. A., Kovalenko, I. G., Poroshina, T. E., Semenchenko, A. V., Provinciali, M., et al. (2005) · Experimental Gerontology · doi:10.1016/j.exger.2005.07.007 · Cited by 402
Self-citationRapamycin decelerates cellular senescence
Demidenko, Z. N., Zubova, S. G., Bukreeva, E. I., Pospelov, V. A., Pospelova, T. V., & Blagosklonny, M. V. (2009) · Cell Cycle · doi:10.4161/cc.8.12.8606 · Cited by 391
Self-citationCalorie restriction and cancer prevention: metabolic and molecular mechanisms
Longo, V. D., & Fontana, L. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.11.004 · Cited by 378
Anisimov, V. N., Berstein, L. M., Popovich, I. G., Zabezhinski, M. A., Egormin, P. A., Piskunova, T. S., Semenchenko, A. V., Tyndyk, M. L., Yurova, M. N., Kovalenko, I. G., et al. (2011) · Aging · doi:10.18632/aging.100273 · Cited by 285
Self-citationThe choice between p53-induced senescence and quiescence is determined in part by the mTOR pathway.
Korotchkina, L. G., Leontieva, O. V., Bukreeva, E. I., Demidenko, Z. N., Gudkov, A. V., & Blagosklonny, M. V. (2010) · Aging · doi:10.18632/aging.100160 · Cited by 278
Self-citation
Research works printed but not linked: 40
- Blagosklonny MV, Campisi J, Sinclair DA. Aging: past, present and future. Aging 2009; 1:1-5; PMID:20157590.
- Blagosklonny MV. Rapamycin and quasi-programmed aging: Four years later. Cell Cycle 2010; 9:1859- 62; PMID:20436272; http://dx.doi.org/10.4161/ cc.9.10.11872. · DOI
- Kaeberlein M, Powers RW, 3rd, Steffen KK, Westman EA, Hu D, Dang N, et al. Regulation of yeast replica- tive lifespan by TOR and Sch9 in response to nutrients. Science 2005; 310:1193-6; PMID:16293764; http:// dx.doi.org/10.1126/science.1115535. · DOI · Paper page
- Powers RW, 3rd, Kaeberlein M, Caldwell SD, Kennedy BK, Fields S. Extension of chronological lifespan in yeast by decreased TOR pathway signaling. Genes Dev 2006; 20:174-84; PMID:16418483; http://dx.doi. org/10.1101/gad.1381406. · DOI · Paper page
- Pan Y, Shadel GS. Extension of chronological lifes- pan by reduced TOR signaling requires downregula- tion of Sch9p and involves increased mitochondrial OXPHOS complex density. Aging 2009; 1:131-45; PMID:20157595.
- Heeren G, Rinnerthaler M, Laun P, von Seyerl P, Kossler S, Klinger H, et al. The mitochondrial ribosom- al protein of the large subunit, Afo1p, determines cel- lular longevity through mitochondrial back-signaling via TOR1. Aging 2009; 1:622-36; PMID:20157544.
- Demidenko ZN, Blagosklonny MV. Growth stimulation leads to cellular senescence when the cell cycle is blocked. Cell Cycle 2008; 7:3355-61; PMID:18948731; http://dx.doi.org/10.4161/ cc.7.21.6919. · DOI · Paper page
- Demidenko ZN, Blagosklonny MV. Quantifying phar- macologic suppression of cellular senescence: pre- vention of cellular hypertrophy versus preservation of proliferative potential. Aging 2009; 1:1008-16; PMID:20157583.
- Demidenko ZN, Shtutman M, Blagosklonny MV. Pharmacologic inhibition of MEK and PI-3K converges on the mTOR/S6 pathway to decelerate cellular senes- cence. Cell Cycle 2009; 8:1896-900; PMID:19478560; http://dx.doi.org/10.4161/cc.8.12.8809. · DOI
- Pospelova TV, Demidenko ZN, Bukreeva EI, Pospelov VA, Gudkov AV, Blagosklonny MV. Pseudo-DNA damage response in senescent cells. Cell Cycle 2009; 8:4112-8; PMID:19946210; http://dx.doi. org/10.4161/cc.8.24.10215. · DOI · Paper page
- Leontieva OV, Gudkov AV, Blagosklonny MV. Weak p53 permits senescence during cell cycle arrest. Cell Cycle 2010; 9:4323-7; PMID:21051933; http:// dx.doi.org/10.4161/cc.9.21.13584. · DOI
- Leontieva OV, Blagosklonny MV. DNA damaging agents and p53 do not cause senescence in quiescent cells, while consecutive re-activation of mTOR is associated with conversion to senescence. Aging 2010; 2:924-35; PMID:21212465.
- Kapahi P, Zid BM, Harper T, Koslover D, Sapin V, Benzer S. Regulation of lifespan in Drosophila by modulation of genes in the TOR signaling pathway. Curr Biol 2004; 14:885-90; PMID:15186745; http:// dx.doi.org/10.1016/j.cub.2004.03.059. · DOI · Paper page
- Kapahi P, Chen D, Rogers AN, Katewa SD, Li PW, Thomas EL, et al. With TOR, less is more: a key role for the conserved nutrient-sensing TOR pathway in aging. Cell Metab 2010; 11:453-65; PMID:20519118; http://dx.doi.org/10.1016/j.cmet.2010.05.001. · DOI · Paper page
- Moskalev AA, Shaposhnikov MV. Pharmacological Inhibition of Phosphoinositide 3 and TOR Kinases Improves Survival of Drosophila melanogaster. Rejuvenation Res 2010; 13:246-7; PMID:20017609; http://dx.doi.org/10.1089/rej.2009.0903. · DOI
- Bjedov I, Toivonen JM, Kerr F, Slack C, Jacobson J, Foley A, et al. Mechanisms of lifespan extension by rapamycin in the fruit fly Drosophila melanogaster. Cell Metab 2010; 11:35-46; PMID:20074526; http:// dx.doi.org/10.1016/j.cmet.2009.11.010. · DOI · Paper page
- Bjedov I, Partridge L. A longer and healthier life with TOR downregulation: genetics and drugs. Biochem Soc Trans 2011; 39:460-5; PMID:21428920; http:// dx.doi.org/10.1042/BST0390460. · DOI
- Partridge L, Alic N, Bjedov I, Piper MD. Ageing in Drosophila: the role of the insulin/Igf and TOR signalling network. Exp Gerontol 2011; 46:376- 81; PMID:20849947; http://dx.doi.org/10.1016/j. exger.2010.09.003. · DOI · Paper page
- Wullschleger S, Loewith R, Hall MN. TOR signaling in growth and metabolism. Cell 2006; 124:471- 84; PMID:16469695; http://dx.doi.org/10.1016/j. cell.2006.01.016. · DOI · Paper page
- Blagosklonny MV, Hall MN. Growth and aging: a common molecular mechanism. Aging 2009; 1:357- 62; PMID:20157523.
- Hands SL, Proud CG, Wyttenbach A. mTOR's role in ageing: protein synthesis or autophagy? Aging 2009; 1:586-97; PMID:20157541.
- Anisimov VN, Egormin PA, Piskunova TS, Popovich IG, Tyndyk ML, Yurova MN, et al. Metformin extends lifespan of HER-2/neu transgenic mice and in com- bination with melatonin inhibits growth of trans- plantable tumors in vivo. Cell Cycle 2010; 9:188- 97; PMID:20016287; http://dx.doi.org/10.4161/ cc.9.1.10407. · DOI · Paper page
- Anisimov VN, Egormin PA, Bershtein LM, Zabezhinskii MA, Piskunova TS, Popovich IG, et al. Metformin decelerates aging and development of mam- mary tumors in HER-2/neu transgenic mice. Bull Exp Biol Med 2005; 139:721-3; PMID:16224592; http:// dx.doi.org/10.1007/s10517-005-0389-9. · DOI
- Blagosklonny MV. Metformin and sex: Why suppres- sion of aging may be harmful to young male mice. Aging 2010; 2:897-9; PMID:21212463.
- Anisimov VN, Khavinson VK, Provinciali M, Alimova IN, Baturin DA, Popovich IG, et al. Inhibitory effect of the peptide epitalon on the development of spontane- ous mammary tumors in HER-2/neu transgenic mice. Int J Cancer 2002; 101:7-10; PMID:12209581; http:// dx.doi.org/10.1002/ijc.10570. · DOI
- Rosenfeld SV, Togo EF, Mikheev VS, Popovich IG, Khavinson V, Anisimov VN. Effect of epitha- lon on the incidence of chromosome aberrations in senescence-accelerated mice. Bull Exp Biol Med 2002; 133:274-6; PMID:12360351; http://dx.doi. org/10.1023/A:1015899003974. · DOI
- Blagosklonny MV. Prevention of cancer by inhib- iting aging. Cancer Biol Ther 2008; 7:1520-4; PMID:18769112; http://dx.doi.org/10.4161/ cbt.7.10.6663. · DOI
- Anisimov VN. Metformin for aging and cancer preven- tion. Aging 2010; 2:760-74; PMID:21084729.
- Blagosklonny MV. Calorie restriction: Decelerating mTOR-driven aging from cells to organisms (including humans). Cell Cycle 2010; 9:683-8; PMID:20139716; http://dx.doi.org/10.4161/cc.9.4.10766. · DOI · Paper page
- Mostoslavsky R, Esteller M, Vaquero A. At the cross- road of lifespan, calorie restriction, chromatin and disease: meeting on sirtuins. Cell Cycle 2010; 9:1907- 12; PMID:20458180; http://dx.doi.org/10.4161/ cc.9.10.11481. · DOI
- Anisimov VN, Berstein LM, Egormin PA, Piskunova TS, Popovich IG, Zabezhinski MA, et al. Metformin slows down aging and extends lifespan of female SHR mice. Cell Cycle 2008; 7:2769-73; PMID:18728386; http://dx.doi.org/10.4161/cc.7.17.6625. · DOI · Paper page
- Anisimov VN, Piskunova TS, Popovich IG, Zabezhinski MA, Tyndyk ML, Egormin PA, et al. Gender differences in metformin effect on aging, lifes- pan and spontaneous tumorigenesis in 129/Sv mice. Aging 2010; 2:945-58; PMID:21164223.
- Cao K, Graziotto JJ, Blair CD, Mazzulli JR, Erdos MR, Krainc D, et al. Rapamycin reverses cellular phenotypes and enhances mutant protein clearance in hutchinson- gilford progeria syndrome cells. Sci Transl Med 2011; 3:89; PMID:21715679; http://dx.doi.org/10.1126/ scitranslmed.3002346. · DOI · Paper page
- Blagosklonny MV. Validation of anti-aging drugs by treating age-related diseases. Aging 2009; 1:281-8; PMID:20157517.
- Bové J, Martinez-Vicente M, Vila M. Fighting neu- rodegeneration with rapamycin: mechanistic insights. Nat Rev Neurosci 2011; 12:437-52; PMID:21772323; http://dx.doi.org/10.1038/nrn3068. · DOI · Paper page
- Zhao C, Vollrath D. mTOR pathway activation in age-related retinal disease. Aging 2011; 3:346-7; PMID:21483039.
- Blagosklonny MV. Aging and immortality: quasi- programmed senescence and its pharmacologic inhibi- tion. Cell Cycle 2006; 5:2087-102; PMID:17012837; http://dx.doi.org/10.4161/cc.5.18.3288. · DOI · Paper page
- Anisimov VN, Zabezhinski MA, Popovich IG, Piskunova TS, Semenchenko AV, Tyndyk ML, et al. Rapamycin extends maximal lifespan in can- cer-prone mice. Am J Pathol 2010; 176:2092- 7; PMID:20363920; http://dx.doi.org/10.2353/ ajpath.2010.091050. · DOI · Paper page
- Ikeno Y, Bronson RT, Hubbard GB, Lee S, Bartke A. Delayed occurrence of fatal neoplastic diseases in ames dwarf mice: correlation to extended longev- ity. J Gerontol A Biol Sci Med Sci 2003; 58:291- 6; PMID:12663691; http://dx.doi.org/10.1093/ gerona/58.4.B291. · DOI · Paper page
- Ikeno Y, Hubbard GB, Lee S, Cortez LA, Lew CM, Webb CR, et al. Reduced incidence and delayed occur- rence of fatal neoplastic diseases in growth hormone receptor/binding protein knockout mice. J Gerontol A Biol Sci Med Sci 2009; 64:522-9; PMID:19228785; http://dx.doi.org/10.1093/gerona/glp017. · DOI · Paper page
Cited by
Hallmarks of aging: An expanding universe
López-Otín, C., Blasco, M. A., Partridge, L., Serrano, M., & Kroemer, G. (2023) · Cell · doi:10.1016/j.cell.2022.11.001 · Cited by 6,549
mTOR is a key modulator of ageing and age-related disease
Johnson, S. C., Rabinovitch, P. S., & Kaeberlein, M. (2013) · Nature · doi:10.1038/nature11861 · Cited by 1,676
From discoveries in ageing research to therapeutics for healthy ageing
Campisi, J., Kapahi, P., Lithgow, G. J., Melov, S., Newman, J. C., & Verdin, E. (2019) · Nature · doi:10.1038/s41586-019-1365-2 · Cited by 1,389
SKN-1/Nrf, stress responses, and aging in Caenorhabditis elegans
Blackwell, T. K., Steinbaugh, M. J., Hourihan, J. M., Ewald, C. Y., & Isik, M. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.06.008 · Cited by 622
Madeo, F., Carmona-Gutierrez, D., Hofer, S. J., & Kroemer, G. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.01.018 · Cited by 630
Metadata
- Authors
- Anisimov, V. N., Zabezhinski, M. A., Popovich, I. G., Piskunova, T. S., Semenchenko, A. V., Tyndyk, M. L., Yurova, M. N., Rosenfeld, S. V., & Blagosklonny, M. V.
- Venue
- Cell Cycle
- Publisher
- Informa UK Limited
- Published
- 2011-12-15
- Volume
- 10
- Issue
- 24
- Pages
- 4230-4236
- ISSN
- 1538-4101
- 1551-4005
- Cited by
- 299
- References
- 11
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Rapamycin increases lifespan and inhibits spontaneous tumorigenesis in inbred female mice. https://app.cochat.ai/papers/10.4161/cc.10.24.18486
- The paper
- Anisimov, V. N., Zabezhinski, M. A., Popovich, I. G., Piskunova, T. S., Semenchenko, A. V., Tyndyk, M. L., Yurova, M. N., Rosenfeld, S. V., & Blagosklonny, M. V. (2011). Rapamycin increases lifespan and inhibits spontaneous tumorigenesis in inbred female mice. Cell Cycle. https://doi.org/10.4161/cc.10.24.18486
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.